Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Skye Bioscience Inc (SKYE)

Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Insider Sale: Chief Development Officer of $SKYE (SKYE) Sells 19,489 Shares Quiver Quantitative, Inc. - Wed Nov 20, 5:36PM CST

Tuan Tu Diep, the Chief Development Officer of $SKYE ($SKYE), sold 19,489 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 19.2%...

SKYE : 4.24 (-0.93%)
Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences GlobeNewswire - Mon Nov 18, 6:00AM CST

SKYE : 4.24 (-0.93%)
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor GlobeNewswire - Thu Nov 14, 6:00AM CST

SKYE : 4.24 (-0.93%)
Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights GlobeNewswire - Thu Nov 7, 3:01PM CST

SKYE : 4.24 (-0.93%)
Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model GlobeNewswire - Mon Nov 4, 6:00AM CST

SKYE : 4.24 (-0.93%)
Skye Bioscience to Announce Third Quarter 2024 Results GlobeNewswire - Fri Nov 1, 6:00AM CDT

SKYE : 4.24 (-0.93%)
Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board GlobeNewswire - Tue Oct 29, 6:00AM CDT

SKYE : 4.24 (-0.93%)
Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences GlobeNewswire - Mon Oct 21, 6:00AM CDT

SKYE : 4.24 (-0.93%)
MarketBeat Week in Review – 10/7 - 10/11 MarketBeat - Sat Oct 12, 6:00AM CDT

Stocks delivered another winning week, but the latest inflation readings dampened hopes for aggressive rate cuts and turned attention toward earnings

NFLX : 899.17 (+1.73%)
NVDA : 143.84 (-1.41%)
META : 561.19 (-0.77%)
AAPL : 229.72 (+0.31%)
SKYE : 4.24 (-0.93%)
XOM : 121.69 (+1.14%)
NU : 13.54 (+1.65%)
CCL : 25.49 (+1.63%)
DAL : 64.41 (+1.21%)
WMT : 88.47 (+1.48%)
PLTR : 61.48 (-1.03%)
Author
Don’t Sleep on Skye Bioscience—This Weight Loss Drug Could Soar MarketBeat - Wed Oct 9, 7:45AM CDT

Skye Bioscience has incredible potential upside, according to Wall Street analysts. It is striving to make a new weight loss drug, that could work with GLP-1s.

SKYE : 4.24 (-0.93%)
NVO : 102.91 (-2.24%)
LLY : 748.36 (-0.67%)

Barchart Exclusives

1 EV Stock Under $10 With 25% Upside Potential Barchart - 1 hour ago
This charging stock has been under heavy pressure lately amid concerns over the fate of EV tax credits. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot